Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Important milestone for Connective Therapeutics' ConXn

Oct. 11, 1996

Federal research grant for novel genetic approach to arthritis

Oct. 11, 1996

Celecoxib development status in Japan

Oct. 11, 1996

Searle continues to investigate COX-2 inhibitors for inflammation

Oct. 11, 1996

Pfizer halts U.S. development of tenidap for rheumatoid arthritis

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Mercian investigators report new antiarthritic compounds

Oct. 4, 1996

Merck Frosst discloses a new series of COX-2 inhibitors

Oct. 4, 1996

Matrix metalloproteinase inhibitors disclosed by Roche Bioscience

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...